SPYRE THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
SPYRE THERAPEUTICS, INC. (SYRE) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 198.46 thousand shares for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-02-19
- SPYRE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 198.46K shares, a 76.75% decline from fiscal 2024.
- SPYRE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 853.71K shares, a 33.88% increase from fiscal 2023.
- SPYRE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 637.69K shares, a 72.99% decline from fiscal 2022.
- SPYRE THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 2.36M shares, a 99.80% decline from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|
| 2025-12-31 | 198.46K shares 10-K · filed 2026-02-19 |
| 2024-12-31 | 853.71K shares 10-K · filed 2025-02-27 |
| 2023-12-31 | 637.69K shares 10-K/A · filed 2024-11-18 |
| 2022-12-31 | 2.36M shares 10-K · filed 2023-03-02 |
| 2021-12-31 | 1.19B shares 10-K · filed 2022-03-08 |
| 2020-12-31 | 367.07K shares 10-K · filed 2021-03-18 |
| 2019-12-31 | 495.96K shares 10-K · filed 2020-02-24 |
| 2018-12-31 | 365.81K shares 10-K · filed 2019-03-07 |
| 2017-12-31 | 556.27K shares 10-K · filed 2018-03-13 |
| 2016-12-31 | 214.69K shares 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |